Identification of the Second Heparin-Binding Domain in Human Complement Factor H

Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining the sialic acid-binding characteristics of fH. We have previously shown that of the 20 short consen...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 160; no. 7; pp. 3342 - 3348
Main Authors Blackmore, Timothy K, Hellwage, Jens, Sadlon, Tania A, Higgs, Naomi, Zipfel, Peter F, Ward, Helena M, Gordon, David L
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 01.04.1998
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining the sialic acid-binding characteristics of fH. We have previously shown that of the 20 short consensus repeat (SCR) modules of fH, SCR 7 contains an important heparin binding site, but other SCRs also play a role in heparin binding. To localize the other sites, we prepared recombinant truncated and SCR deletion mutants of fH and tested them by heparin-agarose affinity chromatography. The 5 C-terminal SCRs were found to contain a heparin binding site as an SCR 7 deletion mutant of the N terminal 15 SCRs did not bind heparin, but a construct consisting of SCRs 16-20 was shown to bind heparin. Double deletion of SCRs 7 and 20 from fH abrogated binding to heparin, indicating that SCR 20 contains a heparin binding site. This finding was confirmed with the observation that attachment of SCR 20 to a group of nonbinding SCRs produced a heparin-binding protein. A protein consisting of SCRs 19 and 20 did not bind heparin, whereas SCRs 18-20 did, indicating that, although SCR 20 contains a heparin binding site, at least two nonspecific adjacent SCRs are required. fH-related protein-3 (FHR-3) possesses an SCR homologous to SCR 7 of fH and bound heparin, whereas FHR-4, which lacks such an SCR, did not. Thus, fH contains two separate heparin binding sites, which are located in SCRs 7 and 20.
AbstractList Abstract Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining the sialic acid-binding characteristics of fH. We have previously shown that of the 20 short consensus repeat (SCR) modules of fH, SCR 7 contains an important heparin binding site, but other SCRs also play a role in heparin binding. To localize the other sites, we prepared recombinant truncated and SCR deletion mutants of fH and tested them by heparin-agarose affinity chromatography. The 5 C-terminal SCRs were found to contain a heparin binding site as an SCR 7 deletion mutant of the N terminal 15 SCRs did not bind heparin, but a construct consisting of SCRs 16–20 was shown to bind heparin. Double deletion of SCRs 7 and 20 from fH abrogated binding to heparin, indicating that SCR 20 contains a heparin binding site. This finding was confirmed with the observation that attachment of SCR 20 to a group of nonbinding SCRs produced a heparin-binding protein. A protein consisting of SCRs 19 and 20 did not bind heparin, whereas SCRs 18–20 did, indicating that, although SCR 20 contains a heparin binding site, at least two nonspecific adjacent SCRs are required. fH-related protein-3 (FHR-3) possesses an SCR homologous to SCR 7 of fH and bound heparin, whereas FHR-4, which lacks such an SCR, did not. Thus, fH contains two separate heparin binding sites, which are located in SCRs 7 and 20.
Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining the sialic acid-binding characteristics of fH. We have previously shown that of the 20 short consensus repeat (SCR) modules of fH, SCR 7 contains an important heparin binding site, but other SCRs also play a role in heparin binding. To localize the other sites, we prepared recombinant truncated and SCR deletion mutants of fH and tested them by heparin-agarose affinity chromatography. The 5 C-terminal SCRs were found to contain a heparin binding site as an SCR 7 deletion mutant of the N terminal 15 SCRs did not bind heparin, but a construct consisting of SCRs 16-20 was shown to bind heparin. Double deletion of SCRs 7 and 20 from fH abrogated binding to heparin, indicating that SCR 20 contains a heparin binding site. This finding was confirmed with the observation that attachment of SCR 20 to a group of nonbinding SCRs produced a heparin-binding protein. A protein consisting of SCRs 19 and 20 did not bind heparin, whereas SCRs 18-20 did, indicating that, although SCR 20 contains a heparin binding site, at least two nonspecific adjacent SCRs are required. fH-related protein-3 (FHR-3) possesses an SCR homologous to SCR 7 of fH and bound heparin, whereas FHR-4, which lacks such an SCR, did not. Thus, fH contains two separate heparin binding sites, which are located in SCRs 7 and 20.
Author Blackmore, Timothy K
Zipfel, Peter F
Gordon, David L
Hellwage, Jens
Higgs, Naomi
Ward, Helena M
Sadlon, Tania A
Author_xml – sequence: 1
  fullname: Blackmore, Timothy K
– sequence: 2
  fullname: Hellwage, Jens
– sequence: 3
  fullname: Sadlon, Tania A
– sequence: 4
  fullname: Higgs, Naomi
– sequence: 5
  fullname: Zipfel, Peter F
– sequence: 6
  fullname: Ward, Helena M
– sequence: 7
  fullname: Gordon, David L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9531293$$D View this record in MEDLINE/PubMed
BookMark eNpNkF1LwzAUhoNMdJv-AhFypVedJx9N1kudHxMGCup1SNvUZTRJbVqG_96OTREOnIvzvA-Hd4JGPniD0AWBGQee3Wysc70P9YwImMkZY5weoTFJU0iEADFCYwBKEyKFPEWTGDcAIIDyE3SSpYzQjI3R63NpfGcrW-jOBo9Dhbu1wW-mCL7ES9Po1vrkzvrS-k98H5y2Hg-z7J32eBFcUxs3GPCjLrrQ4uUZOq50Hc35YU_Rx-PD-2KZrF6enhe3q6TgkncJE1TmlUilzIwuyzkUZs4gBca01gXlstK7D-elBsJzWlJOq2oAc5anLOcpm6Krvbdpw1dvYqecjYWpa-1N6KMigs55ltIBZHuwaEOMralU01qn229FQO16VL89DhlQUu16HFKXB32fO1P-ZQ7FDffr_X1tP9db2xoVna7rgSZqu93-M_0AWk9_sw
CitedBy_id crossref_primary_10_3389_fimmu_2015_00262
crossref_primary_10_1016_j_molimm_2016_03_001
crossref_primary_10_1074_jbc_M709587200
crossref_primary_10_1038_leu_2013_169
crossref_primary_10_1111_imr_12466
crossref_primary_10_1074_jbc_M110_142703
crossref_primary_10_1074_jbc_M513611200
crossref_primary_10_1110_ps_03516504
crossref_primary_10_1111_bph_15307
crossref_primary_10_1002_jbm_a_10104
crossref_primary_10_1038_sj_emboj_7601052
crossref_primary_10_1016_j_molimm_2010_03_007
crossref_primary_10_3389_fimmu_2020_601895
crossref_primary_10_1373_clinchem_2004_042192
crossref_primary_10_1016_j_molimm_2009_02_013
crossref_primary_10_1093_hmg_ddw336
crossref_primary_10_1111_j_1365_2958_2008_06347_x
crossref_primary_10_3389_fimmu_2020_01728
crossref_primary_10_1016_j_molimm_2015_02_032
crossref_primary_10_1074_jbc_M002903200
crossref_primary_10_1097_00041552_200207000_00010
crossref_primary_10_4049_jimmunol_172_10_6195
crossref_primary_10_1006_clim_2001_5043
crossref_primary_10_1006_jmbi_2001_4720
crossref_primary_10_1016_j_crvi_2013_12_003
crossref_primary_10_1111_j_1365_2249_2007_03553_x
crossref_primary_10_3390_biom2010046
crossref_primary_10_1016_j_jmb_2009_10_010
crossref_primary_10_1016_j_vaccine_2008_11_023
crossref_primary_10_1002_eji_200323541
crossref_primary_10_1038_nsmb_2018
crossref_primary_10_1002_1873_3468_12284
crossref_primary_10_1016_j_molimm_2011_07_017
crossref_primary_10_1371_journal_pone_0032187
crossref_primary_10_4049_jimmunol_177_9_6308
crossref_primary_10_4049_jimmunol_181_12_8433
crossref_primary_10_4049_jimmunol_1602017
crossref_primary_10_1016_S0162_3109_99_00024_7
crossref_primary_10_1016_j_jmb_2007_02_038
crossref_primary_10_4049_jimmunol_181_4_2610
crossref_primary_10_1007_s00128_016_1851_2
crossref_primary_10_1074_jbc_M605083200
crossref_primary_10_5551_jat_RV17026
crossref_primary_10_1128_IAI_00658_18
crossref_primary_10_1016_j_preteyeres_2017_03_002
crossref_primary_10_1128_IAI_00313_08
crossref_primary_10_1016_S0171_2985_01_80016_4
crossref_primary_10_4049_jimmunol_181_1_537
crossref_primary_10_1002_path_4811
crossref_primary_10_4049_jimmunol_0804031
crossref_primary_10_1074_jbc_M900814200
crossref_primary_10_1182_bloodadvances_2018025692
crossref_primary_10_1016_S1570_9639_03_00189_4
crossref_primary_10_1074_jbc_M112072200
crossref_primary_10_1177_0961203316642307
crossref_primary_10_1002_humu_20268
crossref_primary_10_1084_jem_20071069
crossref_primary_10_1086_344515
crossref_primary_10_1128_jb_00018_23
crossref_primary_10_1016_j_jmb_2012_09_013
crossref_primary_10_1111_j_1365_2249_2007_03552_x
crossref_primary_10_1016_S0092_8674_01_00214_8
crossref_primary_10_1196_annals_1398_011
crossref_primary_10_1073_pnas_2135497100
crossref_primary_10_4049_jimmunol_182_2_1061
crossref_primary_10_4049_jimmunol_174_10_6250
crossref_primary_10_1093_femspd_ftx049
crossref_primary_10_1107_S0907444911015423
crossref_primary_10_1016_j_virol_2009_10_030
crossref_primary_10_1016_j_jmgm_2011_04_010
crossref_primary_10_1371_journal_pone_0166200
crossref_primary_10_1016_j_semnephrol_2007_02_005
crossref_primary_10_1016_j_jim_2013_02_007
crossref_primary_10_1038_cr_2009_139
crossref_primary_10_1016_j_chom_2012_11_013
crossref_primary_10_1002_ajmg_c_31986
crossref_primary_10_4049_jimmunol_168_4_1886
crossref_primary_10_1586_1744666X_2_5_775
crossref_primary_10_1016_j_matbio_2016_09_002
crossref_primary_10_1074_jbc_M609636200
crossref_primary_10_1182_blood_2007_08_106153
crossref_primary_10_1016_j_molimm_2006_07_287
crossref_primary_10_1016_S0014_5793_99_01554_9
crossref_primary_10_1042_BST0381342
crossref_primary_10_4049_jimmunol_1500793
crossref_primary_10_4049_jimmunol_1801545
crossref_primary_10_1021_bi4003452
crossref_primary_10_1074_jbc_RA119_012305
crossref_primary_10_1016_S0161_5890_00_00024_9
crossref_primary_10_1128_CVI_00452_06
crossref_primary_10_1097_00000658_200211000_00013
crossref_primary_10_4049_jimmunol_163_7_3957
crossref_primary_10_4049_jimmunol_164_11_6075
crossref_primary_10_1074_jbc_RA118_004767
crossref_primary_10_1016_S0162_3109_99_00015_6
crossref_primary_10_1002_jemt_10047
crossref_primary_10_4049_jimmunol_176_3_1305
crossref_primary_10_3389_fimmu_2016_00542
crossref_primary_10_3389_fimmu_2024_1135490
crossref_primary_10_1016_j_imbio_2011_07_028
crossref_primary_10_1016_S0162_3109_99_00022_3
crossref_primary_10_2174_1573399818666220328145046
crossref_primary_10_1038_s42003_022_03094_5
crossref_primary_10_4049_jimmunol_0903596
crossref_primary_10_4239_wjd_v13_i7_498
crossref_primary_10_1291_hypres_26_S55
crossref_primary_10_1016_S0162_3109_00_80300_8
crossref_primary_10_4049_jimmunol_1200386
crossref_primary_10_1038_sj_bjc_6600614
crossref_primary_10_1074_jbc_M110_211839
crossref_primary_10_4049_jimmunol_1201751
crossref_primary_10_1016_j_jmb_2009_06_010
crossref_primary_10_1111_jcmm_16492
crossref_primary_10_1007_s00281_017_0661_x
crossref_primary_10_1006_jmbi_2001_5337
crossref_primary_10_1016_j_preteyeres_2017_06_002
crossref_primary_10_1016_j_jmb_2009_06_013
crossref_primary_10_1016_S0165_5728_02_00272_2
crossref_primary_10_1073_pnas_1017087108
crossref_primary_10_1016_j_jmb_2007_11_015
crossref_primary_10_1016_j_molimm_2022_03_117
crossref_primary_10_1016_j_surg_2004_09_005
crossref_primary_10_4049_jimmunol_169_9_4702
crossref_primary_10_3389_fimmu_2017_00012
crossref_primary_10_1016_S1567_5769_00_00040_0
crossref_primary_10_1016_j_molimm_2006_06_018
crossref_primary_10_1016_S0161_5890_99_00114_5
crossref_primary_10_1074_jbc_274_27_19237
crossref_primary_10_3389_fimmu_2018_01607
crossref_primary_10_1016_j_molimm_2005_05_011
crossref_primary_10_1371_journal_ppat_1003308
crossref_primary_10_1016_j_addr_2011_06_005
crossref_primary_10_1128_JVI_74_12_5659_5666_2000
crossref_primary_10_1161_01_ATV_0000057808_91263_A4
crossref_primary_10_4049_jimmunol_172_5_3111
crossref_primary_10_1016_j_molimm_2006_12_001
crossref_primary_10_1080_08820530701745140
crossref_primary_10_4049_jimmunol_169_12_6935
crossref_primary_10_1016_j_ejim_2013_05_009
crossref_primary_10_1016_j_molimm_2015_03_011
crossref_primary_10_1016_j_molimm_2005_09_016
crossref_primary_10_1086_318201
crossref_primary_10_1177_039463201002300202
crossref_primary_10_1016_j_molimm_2005_09_012
crossref_primary_10_1074_jbc_M113_459040
crossref_primary_10_1086_318203
crossref_primary_10_1042_BJ20120183
crossref_primary_10_1016_S0002_9440_10_61205_9
crossref_primary_10_1128_IAI_70_10_5604_5611_2002
crossref_primary_10_1016_j_jmb_2007_09_026
crossref_primary_10_1111_j_1538_7836_2004_01010_x
crossref_primary_10_2478_v10034_010_0025_5
Cites_doi 10.1097/00001432-199406000-00005
10.1073/pnas.93.20.10996
10.1016/S0021-9258(19)39753-4
10.1006/jmbi.1993.1381
10.1016/S0076-6879(94)39018-5
10.1128/iai.65.2.484-487.1997
10.1021/bi00218a016
10.1084/jem.171.5.1649
10.1042/bj3150523
10.4049/jimmunol.124.2.977
10.1128/iai.60.10.3986-3993.1992
10.1042/bj2490593
10.1073/pnas.75.4.1971
10.1055/s-0038-1649706
10.4049/jimmunol.146.9.3190
10.4049/jimmunol.149.9.2906
10.1084/jem.144.5.1147
10.4049/jimmunol.122.1.75
10.4049/jimmunol.147.2.590
10.1111/j.1365-3083.1992.tb02943.x
10.1016/S0021-9258(18)99058-7
10.1016/S0021-9258(18)55379-5
10.4049/jimmunol.155.1.348
10.1006/mpat.1995.0071
10.1016/S0065-2776(08)60697-5
10.1007/978-3-642-74977-3_8
10.4049/jimmunol.148.10.3313
10.1074/jbc.272.9.5627
10.1016/0378-1119(95)00360-I
10.1002/eji.1830261017
10.4049/jimmunol.155.12.5663
10.4049/jimmunol.157.12.5422
10.1073/pnas.75.5.2416
10.1074/jbc.271.30.18054
10.4049/jimmunol.128.3.1278
10.1073/pnas.73.9.3268
10.4049/jimmunol.134.2.1101
10.1016/0167-5699(94)90155-4
10.1128/iai.62.5.1755-1760.1994
10.1021/bi00129a011
10.1084/jem.146.1.257
10.4049/jimmunol.121.6.2174
10.1016/S0065-2776(08)60868-8
10.1016/0022-2836(91)90666-T
10.1084/jem.174.6.1451
10.1126/science.271.5252.1116
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
DOI 10.4049/jimmunol.160.7.3342
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList CrossRef
AIDS and Cancer Research Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 3348
ExternalDocumentID 10_4049_jimmunol_160_7_3342
9531293
www160_7_3342
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XFK
XJT
YCJ
ZA5
ZE2
ZGI
ZXP
---
-~X
.55
.GJ
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AI.
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
CITATION
7T5
H94
ID FETCH-LOGICAL-c474t-3627bf65779eadd80ce8305033aaac247fa31298da014b2d242ffaddb3b53b453
ISSN 0022-1767
IngestDate Fri Aug 16 23:31:50 EDT 2024
Thu Sep 26 16:59:33 EDT 2024
Sat Sep 28 08:31:14 EDT 2024
Tue Nov 10 19:22:48 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-3627bf65779eadd80ce8305033aaac247fa31298da014b2d242ffaddb3b53b453
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/160/7/3342/1088144/im079803342o.pdf
PMID 9531293
PQID 16284952
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_16284952
crossref_primary_10_4049_jimmunol_160_7_3342
pubmed_primary_9531293
highwire_smallpub1_www160_7_3342
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 19980401
1998-Apr-01
1998-04-01
PublicationDateYYYYMMDD 1998-04-01
PublicationDate_xml – month: 04
  year: 1998
  text: 19980401
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 1998
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2022123114253108800_R1
2022123114253108800_R40
2022123114253108800_R41
2022123114253108800_R11
2022123114253108800_R33
2022123114253108800_R12
2022123114253108800_R34
2022123114253108800_R31
2022123114253108800_R10
2022123114253108800_R32
2022123114253108800_R15
2022123114253108800_R37
2022123114253108800_R16
2022123114253108800_R38
2022123114253108800_R13
2022123114253108800_R35
2022123114253108800_R14
2022123114253108800_R36
2022123114253108800_R9
2022123114253108800_R19
2022123114253108800_R8
2022123114253108800_R7
2022123114253108800_R17
2022123114253108800_R39
2022123114253108800_R6
2022123114253108800_R18
2022123114253108800_R5
2022123114253108800_R4
2022123114253108800_R3
2022123114253108800_R2
2022123114253108800_R30
2022123114253108800_R22
2022123114253108800_R44
2022123114253108800_R23
2022123114253108800_R45
2022123114253108800_R20
2022123114253108800_R42
2022123114253108800_R21
2022123114253108800_R43
2022123114253108800_R26
2022123114253108800_R27
2022123114253108800_R24
2022123114253108800_R46
2022123114253108800_R25
2022123114253108800_R28
2022123114253108800_R29
References_xml – ident: 2022123114253108800_R42
  doi: 10.1097/00001432-199406000-00005
– ident: 2022123114253108800_R11
  doi: 10.1073/pnas.93.20.10996
– ident: 2022123114253108800_R19
  doi: 10.1016/S0021-9258(19)39753-4
– ident: 2022123114253108800_R4
  doi: 10.1006/jmbi.1993.1381
– ident: 2022123114253108800_R3
  doi: 10.1016/S0076-6879(94)39018-5
– ident: 2022123114253108800_R29
  doi: 10.1128/iai.65.2.484-487.1997
– ident: 2022123114253108800_R35
  doi: 10.1021/bi00218a016
– ident: 2022123114253108800_R43
  doi: 10.1084/jem.171.5.1649
– ident: 2022123114253108800_R36
  doi: 10.1042/bj3150523
– ident: 2022123114253108800_R12
  doi: 10.4049/jimmunol.124.2.977
– ident: 2022123114253108800_R40
  doi: 10.1128/iai.60.10.3986-3993.1992
– ident: 2022123114253108800_R37
  doi: 10.1042/bj2490593
– ident: 2022123114253108800_R14
  doi: 10.1073/pnas.75.4.1971
– ident: 2022123114253108800_R27
  doi: 10.1055/s-0038-1649706
– ident: 2022123114253108800_R22
  doi: 10.4049/jimmunol.146.9.3190
– ident: 2022123114253108800_R30
  doi: 10.4049/jimmunol.149.9.2906
– ident: 2022123114253108800_R5
  doi: 10.1084/jem.144.5.1147
– ident: 2022123114253108800_R13
  doi: 10.4049/jimmunol.122.1.75
– ident: 2022123114253108800_R32
  doi: 10.4049/jimmunol.147.2.590
– ident: 2022123114253108800_R46
  doi: 10.1111/j.1365-3083.1992.tb02943.x
– ident: 2022123114253108800_R21
  doi: 10.1016/S0021-9258(18)99058-7
– ident: 2022123114253108800_R17
  doi: 10.1016/S0021-9258(18)55379-5
– ident: 2022123114253108800_R8
  doi: 10.4049/jimmunol.155.1.348
– ident: 2022123114253108800_R44
  doi: 10.1006/mpat.1995.0071
– ident: 2022123114253108800_R1
  doi: 10.1016/S0065-2776(08)60697-5
– ident: 2022123114253108800_R28
  doi: 10.1007/978-3-642-74977-3_8
– ident: 2022123114253108800_R23
  doi: 10.4049/jimmunol.148.10.3313
– ident: 2022123114253108800_R24
  doi: 10.1074/jbc.272.9.5627
– ident: 2022123114253108800_R26
  doi: 10.1016/0378-1119(95)00360-I
– ident: 2022123114253108800_R10
  doi: 10.1002/eji.1830261017
– ident: 2022123114253108800_R9
  doi: 10.4049/jimmunol.155.12.5663
– ident: 2022123114253108800_R18
  doi: 10.4049/jimmunol.157.12.5422
– ident: 2022123114253108800_R15
  doi: 10.1073/pnas.75.5.2416
– ident: 2022123114253108800_R25
  doi: 10.1074/jbc.271.30.18054
– ident: 2022123114253108800_R39
  doi: 10.4049/jimmunol.128.3.1278
– ident: 2022123114253108800_R6
  doi: 10.1073/pnas.73.9.3268
– ident: 2022123114253108800_R16
  doi: 10.4049/jimmunol.134.2.1101
– ident: 2022123114253108800_R20
  doi: 10.1016/0167-5699(94)90155-4
– ident: 2022123114253108800_R41
  doi: 10.1128/iai.62.5.1755-1760.1994
– ident: 2022123114253108800_R33
  doi: 10.1021/bi00129a011
– ident: 2022123114253108800_R7
  doi: 10.1084/jem.146.1.257
– ident: 2022123114253108800_R45
  doi: 10.4049/jimmunol.121.6.2174
– ident: 2022123114253108800_R2
  doi: 10.1016/S0065-2776(08)60868-8
– ident: 2022123114253108800_R34
  doi: 10.1016/0022-2836(91)90666-T
– ident: 2022123114253108800_R31
  doi: 10.1084/jem.174.6.1451
– ident: 2022123114253108800_R38
  doi: 10.1126/science.271.5252.1116
SSID ssj0006024
Score 2.063807
Snippet Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces. Heparin...
Abstract Complement factor H (fH) regulates activation of the alternative pathway of C, reducing the amount of C3b deposited on sialic acid-rich surfaces....
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 3342
SubjectTerms Apolipoproteins - metabolism
Binding Sites - genetics
Binding Sites - immunology
Blood Proteins - metabolism
Complement Factor H - genetics
Complement Factor H - metabolism
Consensus Sequence - immunology
Heparin - immunology
Heparin - metabolism
Humans
Protein Structure, Tertiary
Recombinant Proteins - biosynthesis
Recombinant Proteins - metabolism
Repetitive Sequences, Nucleic Acid - immunology
Sequence Deletion - immunology
Title Identification of the Second Heparin-Binding Domain in Human Complement Factor H
URI http://www.jimmunol.org/cgi/content/abstract/160/7/3342
https://www.ncbi.nlm.nih.gov/pubmed/9531293
https://search.proquest.com/docview/16284952
Volume 160
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIgXBIOJfQB-gKeRktZ2HD-Oj1ENbUJaJ_UtshNb6tQmiLWqtv-F_3Xn2InTqSCGVEVt5FwS3_X8u_N9IPTOmBRwhhARN3kaUZIkkQJUGsVFIZPUEFh0raF4epaMLujJhE16vd-dqKXlQvXzm415Jf_DVTgHfLVZsvfgbEsUTsB34C8cgcNw_Cceuyxb491uzXb_ubVxC1hQbIPBMvo0dYkrX6q5nNZxjc5xbzWBix0_PK6b7vg8hcsgPx20OrV5JK5e0_t6Vyzu-BBqL2ATseu5f_i9H_yss9lKuh7uJ7psUfy5LPym_1ja5LCjcEXjsj-T1XwaPBMuVa8NaAmZAgPu2m30tVewDMzVJE7WNLBrKeBFjXf0KSGu9pZfm23a8Ca9T8HOsXrfz0XtMuP9cHG3yvad1a-NSQRryJLJGiIZEMl4Zok8QA-HXDAbMfptEiKIknhIm2L09jVdUStL5OOGJ1kHPk0x6j8bNjXAGT9DTz2v8ZETs-eop8tt9Mj1Kr3eRo9PfRTGC_RjXe5wZTDIHXZyh-_IHXZyh-FTyx0Ocoed3OHRS3Rx_HX8eRT5zhxRTjldRIB6uDIJ41yAJirSONcpsZWFiJQyH1JuJAEgmRYSLHA1LAAHGgMDFVGMKMrIDtoqq1K_QpjIXJE0SQeaFZQKBT-ZIQMtRS404Ndd9KGZtuynK8CS_YVVuwg3U5tdzeVsBlM6yFarVXfI22bKM9CldoNMlrpaXgEZAGuCwYgdx4n2joLZ9yF793uYffQk_C8O0Nbi11K_Bgy7UG9qSboFpiSaMg
link.rule.ids 315,786,790,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+the+Second+Heparin-Binding+Domain+in+Human+Complement+Factor+H&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Blackmore%2C+Timothy+K.&rft.au=Hellwage%2C+Jens&rft.au=Sadlon%2C+Tania+A.&rft.au=Higgs%2C+Naomi&rft.date=1998-04-01&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=160&rft.issue=7&rft.spage=3342&rft.epage=3348&rft_id=info:doi/10.4049%2Fjimmunol.160.7.3342&rft.externalDBID=n%2Fa&rft.externalDocID=10_4049_jimmunol_160_7_3342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon